Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Cochat

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 11, 2014
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative careDaniel Abramowicz, Pierre Cochat, Frans H J Claas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Nephropathic cystinosis: an international consensus documentFrancesco Emma, Galina Nesterova, Craig Langman, et al.
Human Molecular Genetics|September 16, 2004
Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalitiesMartin Zenker, Thomas Aigner, Olaf Wendler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 2, 2012
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatmentPierre Cochat, Sally-Anne Hulton, Cécile Acquaviva, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2011
Screening for NPHS2 mutations may help predict FSGS recurrence after transplantationTherese C Jungraithmayr, Katrin Hofer, Pierre Cochat, et al.
BMC Pediatrics|May 30, 2019
Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trialBehrouz Kassai, Philippe Bouyé, Brigitte Gilbert-Dussardier, et al.
Transplantation|December 25, 2014
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled TrialNicholas J A Webb, Sarah E Douglas, Azita Rajai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 14, 2021
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical TrialYaacov Frishberg, Georges Deschênes, Jaap W Groothoff, et al.
Kidney International|August 25, 2022
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2Michelle A Baum, Craig Langman, Pierre Cochat, et al.
NDT Plus|May 19, 2015
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Raymond Vanholder, Daniel Abramowicz, Jorge B Cannata-Andia, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 11, 2014
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative careDaniel Abramowicz, Pierre Cochat, Frans H J Claas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
Nephropathic cystinosis: an international consensus documentFrancesco Emma, Galina Nesterova, Craig Langman, et al.
Human Molecular Genetics|September 16, 2004
Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalitiesMartin Zenker, Thomas Aigner, Olaf Wendler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 2, 2012
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatmentPierre Cochat, Sally-Anne Hulton, Cécile Acquaviva, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2011
Screening for NPHS2 mutations may help predict FSGS recurrence after transplantationTherese C Jungraithmayr, Katrin Hofer, Pierre Cochat, et al.
BMC Pediatrics|May 30, 2019
Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trialBehrouz Kassai, Philippe Bouyé, Brigitte Gilbert-Dussardier, et al.
Transplantation|December 25, 2014
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled TrialNicholas J A Webb, Sarah E Douglas, Azita Rajai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 14, 2021
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical TrialYaacov Frishberg, Georges Deschênes, Jaap W Groothoff, et al.
Kidney International|August 25, 2022
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2Michelle A Baum, Craig Langman, Pierre Cochat, et al.
NDT Plus|May 19, 2015
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Raymond Vanholder, Daniel Abramowicz, Jorge B Cannata-Andia, et al.
Pageof 23